JERRIE MORALES: Open Payments
NPI 1962975458 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,200 in 179 payments from 13 companies in 2025. Trend: 2023 $3,812 · 2024 $5,209 · 2025 $4,200
Food & beverage: $4,200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $1,043 |
| Amgen Inc. | 51 | $839 |
| AstraZeneca Pharmaceuticals LP | 15 | $517 |
| UCB, Inc. | 16 | $468 |
| PFIZER INC. | 18 | $411 |
| Novartis Pharmaceuticals Corporation | 11 | $229 |
| Mallinckrodt Hospital Products Inc. | 6 | $216 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $167 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| Janssen Biotech, Inc. | 6 | $99 |
Products named: RINVOQ, SAPHNELO, Bimzelx, SKYRIZI, ENBREL, XELJANZ, COSENTYX, ACTHAR.
Industry payments across OK — which companies pay providers there.
